South & Central America Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Endoscopes, Electrosurgery Devices, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators & Spe

South & Central America Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Endoscopes, Electrosurgery Devices, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators & Speculas, Cutters and Shears, Accessories, and Others), Surgery Type (Right Hemicolectomy, Left Hemicolectomy, Subtotal Colectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others), End User (Hospitals & Clinics, Surgery Centers, and Others), and Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Other Indications)

The colorectal procedure market in South & Central America is expected to grow from US$ 664.91 million in 2022 to US$ 1,427.31 million by 2028. It is estimated to grow at a CAGR of 13.6% from 2022 to 2028.

Development and Launch of Innovative Products

The colorectal procedural market players focus on launching new products to expand their geographic reach and enhance capacities to cater to a greater than existing customer base. In August 2021, Ethicon announced the ECHELON CIRCULAR Powered Stapler results. The product helped in 74% reduction in the anastomotic leak and a 44% reduction in 30-day inpatient hospital readmission rates after colorectal surgery compared to the manual circular staplers. Similarly, Medicare, the popular government insurance program, provides cover for PAP tests, pelvic exams, and clinical colon examinations for colorectal cancer screening every two years. Such programs and developments and launch of new products are likely to bring new trends in the colorectal procedural test market in the coming years, thereby supporting its growth.

Market Overview



The South & Central America colorectal procedure market is further segmented into Argentina, Brazil, and the Rest of South & Central America. The aging population and an increasing colorectal cancer prevalence are they major factors contributing to the market growth in this region. The market growth is also attributed to advancements in technology, which help lower the incidence of colorectal cancers. Colorectal cancer is the third leading cause of cancer in Brazil and poses a significant public health concern. According to the Brazilian Ministry of Health, the incidence of colon cancer has significantly gone up, and it can be associated with the increased pesticide application to the crops. In 2020, ~55,102 new colorectal cases were recorded in Brazil, per the Globocan 2020 data; ~27,346 cases were found in males, while ~27,756 cases were reported in females. ~30% of all colorectal cases correspond to rectal tumors requiring complex multidisciplinary treatment. The Brazilian Society of Surgical Oncology (SBCO) has published guidelines for treating rectal cancer, which address the main issues of the daily clinical practice, to provide surgeons treating rectal cancer with the most up-to-date information based on the best evidence in the literature.

South & Central America Colorectal Procedure Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Procedure Market Segmentation

The South & Central America colorectal procedure market is segmented into product, surgery type, end user, indication and country. Based on product, the South & Central America colorectal procedure market is divided into endoscope, electrosurgery, handheld devices and visual systems, sealing and stapling devices, ligation clips and dilators and speculas, cutter and shears, accessories, and others.

Based on surgery type, the South & Central America colorectal procedure market is segmented into right hemicolectomy, left hemicolectomy, subtotal colectomy, low anterior resection, abdomino-perineal resection, and others (including endoscopic surgery). Based on end user, the South & Central America colorectal procedure market is segmented into hospitals and clinics, surgery centers, and others. Based on indication, the South & Central America colorectal procedure market is segmented into colon polyps, Crohn's disease, colorectal cancer, colitis, irritable bowel syndrome, and other indications. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022. B. Braun Melsungen AG; Boston Scientific Corporation; Cardinal Health Inc.; Ethicon (Johnson & Johnson Services, Inc.); Medtronic; and Olympus Corporation are the leading companies operating in the colorectal procedure market in South & Central America.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America colorectal procedure market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America colorectal procedure market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the colorectal procedure market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution